Market Report Q1 2012
Biotech Back to Business as Q1 Fundraising Cycles Down
By Trista Morrison
Monday, April 16, 2012
Biotech companies raised $5.15 billion in the first quarter of 2012, about 15 percent less than the $6.07 billion raised in the first quarter last year. Public companies felt the pinch slightly more than private companies: The total amount raised by the former dropped about 16 percent compared to the same period last year, while the total amount raised by the latter dropped about 8 percent.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.